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Colistin is an old antibiotic that has recently gained a considerable renewal of
interest as the last-line defense therapy against multidrug-resistant Gram-negative
bacteria. It is administered as colistin methanesulfonate (CMS), an inactive prodrug,
and it was shown that due to slow CMS conversion, colistin plasma concentrations
increase very slowly after treatment initiation, which constitutes the rationale for a
loading dose in critically ill patients. However, faster CMS conversion was observed
in healthy volunteers but using a different CMS brand, which may also have a major
impact on colistin pharmacokinetics. Seventy-three critically ill patients not
undergoing dialysis received multiple doses of CMS. The CMS concentrations were
measured by liquid chromatography-tandem mass spectrometry (LC-MS/MS), and a
pharmacokinetic analysis was conducted using a population approach. We confirmed
that CMS renal clearance and colistin concentrations at steady state are mostly
governed by creatinine clearance, but we predict a typical maximum concentration
of drug in serum (Cmax) of colistin close to 2 mg/liter, occurring 3 h after an initial
dose of 2 million international units (MIU) of CMS. Accordingly, the estimated
colistin half-life (t1/2) was relatively short (3.1 h), with rapid attainment of steady
state. Our results are only partially consistent with other recently published results.
We confirm that the CMS maintenance dose should be adjusted according to renal
function in critically ill patients. However, much higher than expected colistin
concentrations were observed after the initial CMS dose, with rapid steady-state
achievement. These discrepancies challenge the pharmacokinetic rationale for a
loading dose, which may still be appropriate for rapid bacterial eradication and an
improved clinical cure rate.
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